Internal Restructuring Of Subsidiaries Within The Group, And Strategic Investor Purchases 5% Of Issued Share Capital Of Direct Wholly-Owned Subsidiary, Accrelist Medical Aesthetics (BM) Pte. Ltd.

BackFeb 20, 2024
Announcement Title Asset Acquisitions and Disposals
Date & Time of Broadcast Feb 20, 2024 22:26
Status New
Announcement Sub Title Internal Restructuring & Strategic Investor Purchases 5% of Share Capital of Wholly-Owned Subsidiary
Announcement Reference SG240220OTHRA3TI
Submitted By (Co./ Ind. Name) Dr. Terence Tea
Designation Executive Chairman and Managing Director
Description (Please provide a detailed description of the event in the box below) Please refer to the attachment.


  1. Attachment 1 (Size: 713,705 bytes)